Literature DB >> 10828676

Methylglyoxal-induced apoptosis in human prostate carcinoma: potential modality for prostate cancer treatment.

D M Milanesa1, M S Choudhury, C Mallouh, H Tazaki, S Konno.   

Abstract

OBJECTIVE: To examine the cellular effects of methylglyoxal (MG), a toxic physiological metabolite, on human prostatic cancer PC-3 cells.
METHODS: The effects of MG on cell growth and viability were evaluated first, and then its effects on the cell cycle and the glycolytic process were analyzed by Western blots and specific assays. Possible MG-induced apoptosis was also assessed by DNA analysis using agarose gel electrophoresis.
RESULTS: MG > or =3 mM caused severe growth inhibition, resulting in nearly 100% cell death by 24h. The time course study revealed that expression of cyclin D(1), cdk2, and cdk4 was significantly (>50%) downregulated in 3 h of MG (3 mM) exposure, followed by the dephosphorylation of retinoblastoma protein by 6 h. Both the glyceraldehyde-3-phosphate dehydrogenase activity and the cellular lactate level were also reduced by approximately 50 and 80%, respectively, following 6-hour MG exposure. Induction of apoptosis by MG was indicated by partial degradation of poly(ADP-ribose) polymerase and further confirmed by discrete DNA fragmentation detected on an agarose gel.
CONCLUSION: MG is capable of inducing apoptosis in prostatic cancer PC-3 cells, due primarily to a blocking of the cell cycle progression (G(1) arrest) and glycolytic pathway. Therefore, MG could be a potent apoptosis inducer, which may have a potential for prostate cancer treatment.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10828676     DOI: 10.1159/000020226

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  11 in total

1.  A stress-responsive glyoxalase I from the parasitic nematode Onchocerca volvulus.

Authors:  A Sommer; P Fischer; K Krause; K Boettcher; P M Brophy; R D Walter; E Liebau
Journal:  Biochem J       Date:  2001-02-01       Impact factor: 3.857

Review 2.  Methylglyoxal and Its Adducts: Induction, Repair, and Association with Disease.

Authors:  Seigmund Wai Tsuen Lai; Edwin De Jesus Lopez Gonzalez; Tala Zoukari; Priscilla Ki; Sarah C Shuck
Journal:  Chem Res Toxicol       Date:  2022-10-05       Impact factor: 3.973

3.  Effects of methylglyoxal and glyoxalase I inhibition on breast cancer cells proliferation, invasion, and apoptosis through modulation of MAPKs, MMP9, and Bcl-2.

Authors:  Yi Guo; Yuning Zhang; Xunjun Yang; Panpan Lu; Xijuan Yan; Fanglan Xiao; Huaibin Zhou; Chaowei Wen; Mengru Shi; Jianxin Lu; Qing H Meng
Journal:  Cancer Biol Ther       Date:  2015-11-30       Impact factor: 4.742

4.  Methylglyoxal suppresses human colon cancer cell lines and tumor growth in a mouse model by impairing glycolytic metabolism of cancer cells associated with down-regulation of c-Myc expression.

Authors:  Tiantian He; Huaibin Zhou; Chunmei Li; Yuan Chen; Xiaowan Chen; Chenli Li; Jiating Mao; Jianxin Lyu; Qing H Meng
Journal:  Cancer Biol Ther       Date:  2016-07-25       Impact factor: 4.742

5.  Methylglyoxal induces cell death through endoplasmic reticulum stress-associated ROS production and mitochondrial dysfunction.

Authors:  Chi-Ming Chan; Duen-Yi Huang; Yi-Pin Huang; Shu-Hao Hsu; Lan-Ya Kang; Chung-Min Shen; Wan-Wan Lin
Journal:  J Cell Mol Med       Date:  2016-06-16       Impact factor: 5.310

6.  Everolimus inhibits breast cancer cell growth through PI3K/AKT/mTOR signaling pathway.

Authors:  Liyan Du; Xiaomei Li; Linhong Zhen; Weiling Chen; Lingguang Mu; Yang Zhang; Ailin Song
Journal:  Mol Med Rep       Date:  2018-03-16       Impact factor: 2.952

Review 7.  The Dual-Role of Methylglyoxal in Tumor Progression - Novel Therapeutic Approaches.

Authors:  Alessia Leone; Cecilia Nigro; Antonella Nicolò; Immacolata Prevenzano; Pietro Formisano; Francesco Beguinot; Claudia Miele
Journal:  Front Oncol       Date:  2021-03-22       Impact factor: 6.244

8.  Synergistic inhibition of colon cancer growth by the combination of methylglyoxal and silencing of glyoxalase I mediated by the STAT1 pathway.

Authors:  Yuan Chen; Lei Fang; Gefei Li; Jiali Zhang; Changxi Li; Mengni Ma; Chen Guan; Fumao Bai; Jianxin Lyu; Qing H Meng
Journal:  Oncotarget       Date:  2017-06-22

9.  Cell Cycle Arrest and Cytotoxic Effects of SAHA and RG7388 Mediated through p21WAF1/CIP1 and p27KIP1 in Cancer Cells.

Authors:  Umamaheswari Natarajan; Thiagarajan Venkatesan; Vijayaraghavan Radhakrishnan; Shila Samuel; Periannan Rasappan; Appu Rathinavelu
Journal:  Medicina (Kaunas)       Date:  2019-01-29       Impact factor: 2.430

10.  Gut Microbiota Composition across Normal Range Prostate-Specific Antigen Levels.

Authors:  Han-Na Kim; Jae-Heon Kim; Yoosoo Chang; Dongmin Yang; Hyung-Lae Kim; Seungho Ryu
Journal:  J Pers Med       Date:  2021-12-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.